Comparative evaluation of efficiency oftransdermal patches of ketoprofen and diclofenacsodium with oral diclofenac tablet on postendodontic pain reduction following single visitroot canal therapy in symptomatic irreversiblepulpitis- A Randomized Clinical Study. ?

DR PRIYA PORWA0 个研究点目标入组 78 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•Patients complaining of pain in anterior or single-rooted premolar teeth of either jaw
•and diagnosed as symptomatic irreversible pulpitis with or without apical periodontitis
•having pre operative moderate to severe pain indicated for single visit endodontics will
•be included in the study.
•A written informed consent will be taken from all the patients and only those patients
•ready to sign the consent letter will be included in the study

•1. Patients with known hypersensitivity against ketoprofen or diclofenac sodium will be excluded from the study.
•2. patients with history of allergic reactions such as bronchospasm, shock, urticarial,
•etc., following the use of non-steroidal anti-inflammatory drugs (NSAIDs) will be excluded from the study.
•3. Patients with high blood pressure and cardiac conditions will be excluded from the study.
•4. Patients with sinus drainage, pus discharge, acute or chronic apical abscess will be excluded from the study.
•5. Intentional RCT, fractured tooth having cracks or resorption will be excluded from
•6. Patients with active stomach or duodenal ulceration within the last 6 months will be excluded from the study.
•7. Patients undergoing treatment with other NSAIDs or corticosteroids during the
•study period will be excluded from the study.
•8. Patients with developmental anomalies, congenital defects, pathology or open apex,
•with presence of anatomical obstacles such as calcifications in the canals or any
•anticipated procedural difficulties related to study teeth will be excluded from the study.
•9. Pregnant and lactating women will be excluded from the study.
•10. Patients who have taken NSAIDS or antibiotics within 24 hrs before administration
•of study drug will be excluded from the study

发起方

DR PRIYA PORWA